Administrators slim down Epsilon board as investigations continue by Steve Jones February 15, 2024February 15, 2024 The fallout from the voluntary administration of Epsilon Healthcare has continued with the removal of two […]
Epsilon conflict deepens as chairman-owned shareholder plots removal of board director by Steve Jones December 4, 2023December 7, 2023
Boardroom drama erupts at Epsilon as CEO sacked amid calls to oust chairman by Steve Jones November 22, 2023November 23, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023April 30, 2024
Epsilon rebrands manufacturing and telehealth clinic operations by Steve Jones August 7, 2023April 30, 2024
Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023April 30, 2024
Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma by Martin Lane and Steve Jones May 23, 2023April 30, 2024
